Online citations, reference lists, and bibliographies.
← Back to Search

Macrophage Functionality And Homeostasis In Response To Oligoethyleneglycol-coated IONPs: Impact Of A Dendritic Architecture.

A. Casset, J. Jouhannaud, A. Garofalo, C. Spiegelhalter, D. Nguyen, D. Felder-Flesch, G. Pourroy, F. Pons
Published 2019 · Chemistry, Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
The engineering of iron oxide nanoparticles (IONPs) for biomedical use has received great interest over the past decade. In the present study we investigated the biocompatibility of IONPs grafted with linear (2P) or generation 1 (2PG1) or 2 (2PG2) dendronized oligoethyleneglycol units in THP-1-derived macrophages. To evaluate IONP effects on cell functionality and homeostasis, mitochondrial function (MTT assay), membrane permeability (LDH release), inflammation (IL-8), oxidative stress (reduced glutathione, GSH), NLRP3 inflammasome activation (IL-1β) and nanoparticle cellular uptake (intracellular iron content) were quantified after a 4-h or 24-h cell exposure to increasing IONP concentrations (0-300 µg Fe/mL). IONPs coated with a linear molecule, NP10COP@2P, were highly taken up by cells and induced significant dose-dependent IL-8 release, oxidative stress and NLRP3 inflammasome activation. In comparison, IONPs coated with dendrons of generation 1 (NP10COP@2PG1) and 2 (NP10COP@2PG2) exhibited better biocompatibility. Effect of the dendritic architecture of the surface coating was investigated in a kinetic experiment involving cell short-term exposure (30 min or 1 h 30) to the two dendronized IONPs. NP10COP@2PG2 disrupted cellular homeostasis (LDH release, IL-1β and IL-8 secretion) to a greater extend than NP10COP@2PG1, which makes this last IONP the best candidate as MRI contrast or theranostic agent.
This paper references
10.1016/j.taap.2011.03.011
Efficient internalization of silica-coated iron oxide nanoparticles of different sizes by primary human macrophages and dendritic cells.
A. Kunzmann (2011)
10.1016/j.talanta.2006.02.009
Development of a fluorescence-based microtiter plate method for the measurement of glutathione in yeast.
Kamil Lewicki (2006)
10.1002/jso.24164
Sentinel lymph node identification using superparamagnetic iron oxide particles versus radioisotope: The French Sentimag feasibility trial
Jean-Louis Houpeau (2016)
10.3109/17435390.2013.822115
Iron oxide nanoparticle agglomeration influences dose rates and modulates oxidative stress-mediated dose–response profiles in vitro
G. Sharma (2014)
10.1016/j.taap.2017.01.012
Phagolysosome acidification is required for silica and engineered nanoparticle‐induced lysosome membrane permeabilization and resultant NLRP3 inflammasome activity
F. Jessop (2017)
10.1504/IJBNN.2010.034651
Synthesis, surface architecture and biological response of superparamagnetic iron oxide nanoparticles for application in drug delivery: a review
M. Mahmoudi (2010)
10.1007/s00330-002-1721-7
Ferucarbotran (Resovist): a new clinically approved RES-specific contrast agent for contrast-enhanced MRI of the liver: properties, clinical development, and applications
P. Reimer (2002)
10.1016/j.bbrc.2013.10.115
SPION primes THP1 derived M2 macrophages towards M1-like macrophages.
Amit Laskar (2013)
10.3389/fphar.2015.00055
M2 polarization enhances silica nanoparticle uptake by macrophages
J. Hoppstädter (2015)
10.2147/IJN.S33120
Studying the effect of particle size and coating type on the blood kinetics of superparamagnetic iron oxide nanoparticles
F. Roohi (2012)
10.2147/IJN.S82714
Flow cytometry for intracellular SPION quantification: specificity and sensitivity in comparison with spectroscopic methods
R. Friedrich (2015)
10.1002/smll.200902084
High intracellular iron oxide nanoparticle concentrations affect cellular cytoskeleton and focal adhesion kinase-mediated signaling.
S. Soenen (2010)
10.1080/10934520600966177
Toxicity of Metal Oxide Nanoparticles in Mammalian Cells
H. Jeng (2006)
10.1002/cmmi.416
Properties and suspension stability of dendronized iron oxide nanoparticles for MRI applications.
B. Basly (2011)
10.1016/j.toxlet.2012.01.008
Oxidative damage to biological macromolecules in human bone marrow mesenchymal stromal cells labeled with various types of iron oxide nanoparticles.
B. Novotná (2012)
10.1016/j.biomaterials.2008.04.016
Universal cell labelling with anionic magnetic nanoparticles.
C. Wilhelm (2008)
10.1039/b823187g
Water soluble dendronized iron oxide nanoparticles.
T. J. Daou (2009)
10.1093/ibd/izy063
Adverse Reactions After Intravenous Iron Infusion Among Inflammatory Bowel Disease Patients in the United States, 2010-2014.
Eboselume Akhuemonkhan (2018)
10.1021/acs.molpharmaceut.7b00904
Evaluation of the Active Targeting of Melanin Granules after Intravenous Injection of Dendronized Nanoparticles.
C. Bordeianu (2018)
10.2147/IJN.S28316
Enhanced cellular uptake of aminosilane-coated superparamagnetic iron oxide nanoparticles in mammalian cell lines
X. Zhu (2012)
10.1016/S0927-7765(99)00156-3
'Stealth' corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption.
Gref (2000)
10.1016/j.biomaterials.2010.08.075
Cytotoxic effects of iron oxide nanoparticles and implications for safety in cell labelling.
Stefaan J.H. Soenen (2011)
10.1016/j.biomaterials.2008.09.050
The influence of protein adsorption on nanoparticle association with cultured endothelial cells.
Morton Ehrenberg (2009)
10.1039/c2dt31788e
Effect of the nanoparticle synthesis method on dendronized iron oxides as MRI contrast agents.
B. Basly (2013)
10.1016/0921-4526(93)90108-I
Recent advances in magnetic structure determination by neutron powder diffraction
J. Rodríguez-Carvajal (1993)
10.1021/cr2002596
Assessing the in vitro and in vivo toxicity of superparamagnetic iron oxide nanoparticles.
M. Mahmoudi (2012)
10.1111/nyas.12458
Mechanism of NLRP3 inflammasome activation
F. Sutterwala (2014)
10.1126/science.1156995
Innate Immune Activation Through Nalp3 Inflammasome Sensing of Asbestos and Silica
Catherine Dostert (2008)
10.1039/c6nr04042j
Quantifying intra- and extracellular aggregation of iron oxide nanoparticles and its influence on specific absorption rate.
Seongho Jeon (2016)
10.1016/j.toxlet.2015.10.018
Protein corona acts as a protective shield against Fe3O4-PEG inflammation and ROS-induced toxicity in human macrophages.
V. Escamilla-Rivera (2016)
10.1039/c4nr02008a
Transport across the cell-membrane dictates nanoparticle fate and toxicity: a new paradigm in nanotoxicology.
D. Guarnieri (2014)
10.1016/j.msec.2017.03.060
Simplified preparation and characterization of magnetic hydroxyapatite-based nanocomposites.
Stefania Scialla (2017)
10.1016/j.biomaterials.2011.09.087
The role of iron redox state in the genotoxicity of ultrafine superparamagnetic iron oxide nanoparticles.
N. Singh (2012)
10.2147/IJN.S13244
Concentration-dependent toxicity of iron oxide nanoparticles mediated by increased oxidative stress
S. Naqvi (2010)
10.1039/C4TB01954G
Validation of a dendron concept to tune colloidal stability, MRI relaxivity and bioelimination of functional nanoparticles.
A. Walter (2015)
10.1016/j.toxlet.2012.12.008
Immunomodulatory properties of multi-walled carbon nanotubes in peripheral blood mononuclear cells from healthy subjects and allergic patients.
G. Laverny (2013)
10.1186/1743-8977-10-46
Iron oxide nanoparticles suppress the production of IL-1beta via the secretory lysosomal pathway in murine microglial cells
Hsin-Ying Wu (2013)
10.1016/j.immuni.2013.05.016
K⁺ efflux is the common trigger of NLRP3 inflammasome activation by bacterial toxins and particulate matter.
Raúl Muñoz-Planillo (2013)
10.1021/CM103188A
Magnetic Iron Oxide Nanoparticles in 10−40 nm Range: Composition in Terms of Magnetite/Maghemite Ratio and Effect on the Magnetic Properties
J. Salazar (2011)
10.1002/jmri.22683
Coronary MR angiography using citrate‐coated very small superparamagnetic iron oxide particles as blood‐pool contrast agent: Initial experience in humans
M. Wagner (2011)
10.1016/J.BIOMATERIALS.2006.12.003
Effect of ultrasmall superparamagnetic iron oxide nanoparticles (Ferumoxtran-10) on human monocyte-macrophages in vitro.
K. Mueller (2007)
10.1016/j.biomaterials.2008.05.015
Size, charge and concentration dependent uptake of iron oxide particles by non-phagocytic cells.
D. Thorek (2008)
10.1021/nn101643u
Effects of nanoparticle size on cellular uptake and liver MRI with polyvinylpyrrolidone-coated iron oxide nanoparticles.
J. Huang (2010)
10.1016/J.TIV.2005.06.034
In vitro toxicity of nanoparticles in BRL 3A rat liver cells.
S. Hussain (2005)
10.1021/nn402145t
Dysregulation of macrophage activation profiles by engineered nanoparticles.
V. Kodali (2013)
10.1074/jbc.M608083200
ATP Activates a Reactive Oxygen Species-dependent Oxidative Stress Response and Secretion of Proinflammatory Cytokines in Macrophages*
Christiane Monteiro da Cruz (2007)
10.1007/s12013-012-9367-9
Oxidative Stress and Dermal Toxicity of Iron Oxide Nanoparticles In Vitro
A. Murray (2012)
10.1080/17474086.2018.1518712
Ferumoxytol for the treatment of iron deficiency anemia
M. Auerbach (2018)
10.1097/01.rli.0000101027.57021.28
Macrophage Endocytosis of Superparamagnetic Iron Oxide Nanoparticles: Mechanisms and Comparison of Ferumoxides and Ferumoxtran-10
I. Raynal (2004)
10.1016/j.actbio.2017.05.047
Time-course assessment of the aggregation and metabolization of magnetic nanoparticles.
J. M. Rojas (2017)
10.1016/j.colsurfb.2010.03.053
Cell-specific cytotoxicity of dextran-stabilized magnetite nanoparticles.
J. Ding (2010)
10.1371/journal.pone.0010008
Aspergillus fumigatus Stimulates the NLRP3 Inflammasome through a Pathway Requiring ROS Production and the Syk Tyrosine Kinase
Najwane Saïd-Sadier (2010)
10.1021/nn100190v
PEG-mediated synthesis of highly dispersive multifunctional superparamagnetic nanoparticles: their physicochemical properties and function in vivo.
C. Sun (2010)
10.1038/nm1467
Artificially engineered magnetic nanoparticles for ultra-sensitive molecular imaging
Jaehyun Lee (2007)
10.1021/BC050050Z
Folate-conjugated iron oxide nanoparticles for solid tumor targeting as potential specific magnetic hyperthermia mediators: synthesis, physicochemical characterization, and in vitro experiments.
Fabio Sonvico (2005)
10.1002/smll.200800199
Assessing methods for blood cell cytotoxic responses to inorganic nanoparticles and nanoparticle aggregates.
B. Díaz (2008)
10.2147/IJN.S33593
Actively-targeted LTVSPWY peptide-modified magnetic nanoparticles for tumor imaging
Li-Yong Jie (2012)
10.1074/jbc.M114.610899
Silver Nanoparticles Induce Degradation of the Endoplasmic Reticulum Stress Sensor Activating Transcription Factor-6 Leading to Activation of the NLRP-3 Inflammasome
J. Simard (2015)
10.1021/ja2084338
Nanoparticle size and surface chemistry determine serum protein adsorption and macrophage uptake.
Carl D. Walkey (2012)
10.1111/aji.12129
Effect of Culture Conditions on the Phenotype of THP‐1 Monocyte Cell Line
P. Aldo (2013)
10.1016/j.etp.2014.11.010
In vitro toxicity of iron oxide nanoparticle: oxidative damages on Hep G2 cells.
L. Sadeghi (2015)
10.1016/j.toxlet.2009.03.014
Size-dependent toxicity of metal oxide particles--a comparison between nano- and micrometer size.
H. Karlsson (2009)
10.3390/ijms13055554
Dextran and Polymer Polyethylene Glycol (PEG) Coating Reduce Both 5 and 30 nm Iron Oxide Nanoparticle Cytotoxicity in 2D and 3D Cell Culture
M. Yu (2012)
10.1021/nn305719y
Biodegradation of iron oxide nanocubes: high-resolution in situ monitoring.
Lénaic Lartigue (2013)
10.1016/j.jhazmat.2015.10.041
Magnetic ferroferric oxide nanoparticles induce vascular endothelial cell dysfunction and inflammation by disturbing autophagy.
L. Zhang (2016)
10.1039/c3mt00167a
Effects of metal(loid)-based nanomaterials on essential element homeostasis: the central role of nanometallomics for nanotoxicology.
F. Benetti (2014)
10.1186/1743-8977-7-39
The nanosilica hazard: another variable entity
D. Napierska (2010)
10.1016/j.biotechadv.2015.02.003
Tailored functionalization of iron oxide nanoparticles for MRI, drug delivery, magnetic separation and immobilization of biosubstances.
K. Holá (2015)
10.2147/IJN.S113425
Iron oxide nanoparticles modulate lipopolysaccharide-induced inflammatory responses in primary human monocytes
S. Grosse (2016)
10.1371/journal.pone.0143077
Modulation of Human Macrophage Responses to Mycobacterium tuberculosis by Silver Nanoparticles of Different Size and Surface Modification
S. Sarkar (2015)
10.1038/ni.1631
Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization
V. Hornung (2008)
10.1016/j.toxlet.2014.02.025
The role of reactive oxygen species in the genotoxicity of surface-modified magnetite nanoparticles.
M. Mesárošová (2014)
10.1016/J.BIOMATERIALS.2004.05.022
Cytotoxicity suppression and cellular uptake enhancement of surface modified magnetic nanoparticles.
A. Gupta (2005)
10.1016/j.biomaterials.2011.07.026
Dendronized iron oxide nanoparticles for multimodal imaging.
G. Lamanna (2011)
10.1007/s00395-013-0328-2
Rapid binding of electrostatically stabilized iron oxide nanoparticles to THP-1 monocytic cells via interaction with glycosaminoglycans
A. Ludwig (2013)
10.1107/S0021889887087090
Rietveld refinement of Debye–Scherrer synchrotron X‐ray data from Al2O3
P. Thompson (1987)
10.1007/s003300050067
Signal changes in liver and spleen after Endorem administration in patients with and without liver cirrhosis
W. Hundt (2000)
10.2147/IJN.S102730
Oxidative stress response in neural stem cells exposed to different superparamagnetic iron oxide nanoparticles
Igor M. Pongrac (2016)
10.1148/RADIOLOGY.175.2.2326475
Ultrasmall superparamagnetic iron oxide: an intravenous contrast agent for assessing lymph nodes with MR imaging.
R. Weissleder (1990)
10.1021/CM5019025
Mastering the Shape and Composition of Dendronized Iron Oxide Nanoparticles To Tailor Magnetic Resonance Imaging and Hyperthermia
A. Walter (2014)
10.4049/jimmunol.1500509
Multiple Cathepsins Promote Pro–IL-1β Synthesis and NLRP3-Mediated IL-1β Activation
G. Orlowski (2015)
10.1039/b920348f
Dendronized iron oxide nanoparticles as contrast agents for MRI.
B. Basly (2010)
10.1016/j.scitotenv.2010.07.025
In vitro evaluation of the cytotoxicity of iron oxide nanoparticles with different coatings and different sizes in A3 human T lymphocytes.
Er-Bo Ying (2010)
10.1016/j.tibs.2016.09.002
Mechanism and Regulation of NLRP3 Inflammasome Activation.
Y. He (2016)
10.1021/LA0503451
Methotrexate-modified superparamagnetic nanoparticles and their intracellular uptake into human cancer cells.
N. Kohler (2005)
10.1039/C4NJ00654B
Efficient synthesis of small-sized phosphonated dendrons: potential organic coatings of iron oxide nanoparticles
A. Garofalo (2014)
10.1021/cr400714j
(Intra)cellular stability of inorganic nanoparticles: effects on cytotoxicity, particle functionality, and biomedical applications.
S. Soenen (2015)
10.1016/j.tiv.2015.04.003
Cell compatibility of a maghemite/polymer biomedical nanoplatform.
Lamiaa M. A. Ali (2015)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar